It was known that distal coronary protection during primary PCI had no long-term effects
on ventricular remodelling is not well established. This prospective randomised study
was designed to validate the efficacy of distal coronary protection on ventricular
remodelling and microvascular obstruction at 6 months after AMI. AMI patients with
onset time of 12 h or less were randomly assigned into the distal coronary protection group (group
P) with percutaneous guardwire, or no protection group (group N). Immediately after
PCI, antegrade flow and myocardial perfusion were evaluated according to TIMI and
TMP grading, respectively. QCA (quantitative coronary angiography) analysis, at the
time of immediate post-PCI and 6 months follow-up and clinical outcome during follow-up
period. Before the discharge, cardiac MRI imagings were obtained. Microvascular obstruction
(MVO) was graded in perfusion imaging. Grade III means severe degree of MVO showing
no evidence of microperfusion after 10 min of contrast injection. 88 patients were enrolled and among them, 66 patients including
2 mortality cased finished 6 months follow-up. No difference was found in demographic
characteristics and major risk factors. Stent was longer in group P (27.23 mm vs. 24.36 mm, p = 0.03) and similar in diameter (3.17 mm vs. 3.10 mm, p = 0.48). Distal protection did not show any benefit in terms of left ventricular volume,
infraction size measured by cardiac MRI, post-PCI and 6 months follow-up. MRI ejection fraction had no difference both at baseline and 6 months
follow-up. TMP grade III was 40% in group P, 29% in group N, (p = 0.07) MVO grade 0/I was 27% in group P, 35% in group N immediately after PCI. Distal
protection device have tendency to improve microvascular perfusion but it seems not
to affect the ventricular remodelling and dysfunction.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Heart, Lung and CirculationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2007 Published by Elsevier Inc.